Lesion of the Urinary Bladder Microbiome in Neurogenic Dysfunction after Spinal Cord Injury
DOI:
https://doi.org/10.5281/zenodo.20008519Keywords:
Keywords: urinary tract infections; neurogenic bladder dysfunction; alpha diversity; antimicrobial resistance; probiotic correction.Abstract
Introduction. Spinal cord injury is one of the most severe forms of neurological damage. It almost always leads to neurogenic bladder dysfunction. This, in turn, leads to a high incidence of recurrent urinary tract infections, which are linked to disturbances in the urobiome. The aim of the study is to summarize current scientific data on bladder microbiome disorders in neurogenic dysfunction after spinal cord injury and to assess the impact of drainage methods, antibiotic therapy, and microbiome-oriented interventions on the course of urinary tract infections. Materials and methods. The study was conducted in a systematic review format in accordance with PRISMA recommendations. Clinical, experimental, and randomized studies were analyzed, followed by qualitative and quantitative data synthesis. It was established that neurogenic dysfunction after spinal cord injury is associated with persistent urobiome dysbiosis, characterized by decreased alpha diversity and a reduction in Lactobacillus spp., with the dominance of Enterobacteriaceae and Pseudomonadaceae. Intermittent self-catheterization is associated with a lower incidence of urinary tract infections and greater microbiome diversity than indwelling catheterization. A high level of antimicrobial resistance was identified, including ESBL-producing strains and carbapenem-resistant Pseudomonas aeruginosa, which sustains a vicious cycle of «dysbiosis – infection – antibiotic therapy». The potential effectiveness of probiotic and immunotropic strategies has been demonstrated, with reductions in infection recurrence rates of 21–32%. The practical value of the results lies in the systematization of data on the disruption of the uromicrobiome, a key element in the pathogenesis of neurogenic dysfunction after spinal cord injury. It is substantiated that microbiome-oriented approaches, early monitoring, and catheterization optimization can significantly improve infection prevention and rehabilitation outcomes. Conclusions. Spinal trauma leads to deep dysbiosis of the uromicrobiome. It is seen as a decrease in the alpha-diversity index and in Lactobacillus spp. Less than 5 % and predominance of E. coli (38–45 %), K. pneumoniae (18–24 %) і P. aeruginosa (12–17 %). Draining of the urinary bladder really influences the microbiological profile. Interruptable catheterization is associated with the lowest frequency of symptomatic urinary tract infections and the highest microbial diversity index. Constant urethral catheterization leads to the formation of stable polymicrobial biofilms and a threefold increase in microbiota abundance. Antimicrobial resistance in neurogenic dysfunction after spinal trauma remains critically high. ESBL-production revealed in 34–58 % of isolates, whereas carbapenem-resistance of P. aeruginosa was found in 15–22 % cases. Тривале та нераціональне використання антибіотиків є незалежним чинником поглиблення дисбіозу (OR = 2,4; 95 % ДІ: 1,7–3,4), підтримуючи порочне коло та вимагаючи принципово нових терапевтичних підходів. Microbiome-oriented correction strategies show clinically important efficacy. Intravesical introduction of L. rhamnosus GG decreases frequency of recurrent urinary infections in 32 % (95 % DІ: 18–46 %), usage of Uro-Vaxom на 21 % (95 % DІ: 8–34 %). Transplantation of fecal microflora has shown promise in animal models. Early microbiological monitoring with molecular typing, application of interruptible self-catheterization, are priorities of preventive medicine in spinal trauma. Perspectives of future investigations are connected with randomized clinical examinations of fecal microflora transplantation, elaboration of personal uromicrobial profiling on the basis of new generation sequencing.
References
Zhang J, Lei Y, Du H, Li Z, Wang X, Yang D, et al. Exploring urinary microbiome: insights into neurogenic bladder and improving management of urinary tract infections. Front Cell Infect Microbiol. 2025;15:1512891. doi: 10.3389/fcimb.2025.1512891.
Dalvi H, De Nisco NJ. The evolving world of the urinary microbiome. Curr Opin Urol. 2024;34(6):422–427. doi: 10.1097/MOU.0000000000001222.
Kustrimovic N, Bilato G, Mortara L, Baci D. The urinary microbiome in health and disease: relevance for bladder cancer. Int J Mol Sci. 2024;25(3):1732. doi: 10.3390/ijms25031732.
Lane G, Gracely A, Bassis C, Greiman SE, Romo PB, Clemens JQ, et al. Distinguishing features of the urinary bacterial microbiome in patients with neurogenic lower urinary tract dysfunction. J Urol. 2022;207(3):627–634. doi: 10.1097/JU.0000000000002274.
Chorbińska J, Krajewski W, Nowak Ł, Małkiewicz B, Del Giudice F, Szydełko T. Urinary microbiome in bladder diseases: review. Biomedicines. 2023;11(10):2816. doi: 10.3390/biomedicines11102816.
Milicevic S, Sekulic A, Nikolic D, Tomasevic-Todorovic S, Lazarevic K, Pelemis S, et al. Urinary tract infections in relation to bladder emptying in patients with spinal cord injury. J Clin Med. 2024;13(13):3898. doi: 10.3390/jcm13133898.
Ross SS, Forster CS, Borawski KM. Urinary tract infection and neuropathic bladder. Urol Clin North Am. 2024;51(4):551–559. doi: 10.1016/j.ucl.2024.06.009.
Ferreira NJS, Branco RA, Pimentel SC, Paço MAS, Coelho IMSR, Serpa LEPR. Microbiological profile and antibiotic susceptibility profile of urine cultures in patients with spinal cord injury-retrospective study. Porto Biomed J. 2024;9(6):272. doi: 10.1097/j.pbj.0000000000000272.
Tyagi P, Tyagi S, Stewart L, Glickman S. SWOT and root cause analyses of antimicrobial resistance to oral antimicrobial treatment of cystitis. Antibiotics. 2024;13(4):328. doi: 10.3390/antibiotics13040328.
Groah SL, Rounds AK, Pérez-Losada M. Intravesical Lactobacillus rhamnosus GG alters urobiome composition and diversity among people with neurogenic lower urinary tract dysfunction. Top Spinal Cord Inj Rehabil. 2023;29(3):44–57. doi: 10.46292/sci23-00004.
Valido E, Bertolo A, Wöllner J, Pannek J, Krebs J, Stoyanov J. Effects of Uro-Vaxom versus placebo on the urinary tract microbiome in individuals with spinal cord injury in a randomized controlled pilot trial (Uro-Vaxom pilot). Sci Rep. 2025;15:12825. doi: 10.1038/s41598-025-96939-y.
Hoque MM, Noorian P, Espinoza-Vergara G, To J, Leo D, Chari P, et al. Prediction of symptomatic and asymptomatic bacteriuria in spinal cord injury patients using machine learning. Microbiome. 2025;13(1):246. doi: 10.1186/s40168-025-02213-8.
Nikitaiev SV. Assessment of vesicoureteral reflux in neurogenic bladder dysfunction and selection of treatment strategy. Klin Prak Prev Med. 2023;5:17–24. doi: 10.31612/2616-4868.5.2023.03.
Stoieva T, Godlevska T, Fedin M. Neurogenic voiding dysfunction in children: challenges of wartime. Ukr J Nephrol Dial. 2023;2(78):91–99. doi: 10.31450/ukrjnd.2(78).2023.10.
Valido E, Bertolo A, Fränkl GP, Itodo OA, Pinheiro T, Pannek J, Kopp-Heim D, et al. Systematic review of the changes in the microbiome following spinal cord injury: animal and human evidence. Spinal Cord. 2022;60:288–300. doi: 10.1038/s41393-021-00737-y.
Xie H, Zhang H, Zhou L, Chen J, Yao S, He Q, et al. Fecal microbiota transplantation promotes functional recovery in mice with spinal cord injury by modulating the spinal cord microenvironment. J Transl Med. 2025;23(1):210. doi: 10.1186/s12967-025-06232-9.
Sopel A, Szczuciński W, Gosiewski T, Salamon D. The role of fecal microbiota transplantation in selected neurodegenerative diseases and neurodevelopmental disorders. Prz Gastroenterol. 2025;20(2):127–141. doi: 10.5114/pg.2024.146118.
Bertolo A, Wettstein R, Valido E, Capossela S, Nyfeler N, Stoyanov J. Microbial and inflammatory profiling of pressure injuries and urinary tract infections in spinal cord injury: a prospective cohort study. Sci Rep. 2026. doi: 10.1038/s41598-026-45422-3.
Morsli M, Salipante F, Gelis A, Magnan C, Guigon G, Lavigne JP, et al. Evolution of the urinary microbiota in spinal cord injury patients with decubitus ulcer: a snapshot study. Int Wound J. 2024;21(1):e14626. doi: 10.1111/iwj.14626.
Sevilla Torres E, Soto-Junco EJ, Baizan Orias SD, Rojas Peláez A, Sáenz Araya D, Lizano Guevara F. Neurogenic voiding dysfunction in spinal cord injury and stroke: urodynamic evaluation, functional classification, and therapeutic strategies. Cureus. 2025;17(8):e89348. doi: 10.7759/cureus.89348.
Fitzpatrick MA, Nwafo N. Urinary tract infection diagnostic and management considerations in people with spinal cord injury and neurogenic bladder. Infect Dis Clin North Am. 2024;38(2):381–393. doi: 10.1016/j.idc.2024.03.012.
Nikitin OD, Pasechnikov SP, Golovko SV, Tkachenko SV, Slobodyanyuk EM. Individualized approach to upper urinary tract drainage after retroperitoneoscopic ureterolithotomy. Klin Prak Prev Med. 2024;4(34):6–12. doi: 10.31612/2616-4868.4.2024.01.
Fitzpatrick MA, Wirth M, Solanki P, Burns SP, Suda KJ, Weaver FM, et al. A survey of knowledge, experiences, and quality of life impacts related to urinary tract infections among people with neurogenic bladder. J Spinal Cord Med. 2026;49(2):262–270. doi: 10.1080/10790268.2025.2503051.
Melnyk OV, Kovalenko IV, Vorobets MZ, Chaplyk VV, Onufrovych OK, Kovalchuk IM, et al. Microflora of combat wounds of pelvic organs in men and dysbiosis of the genitourinary system. Klin Prak Prev Med. 2024;4(34):42–49. doi: 10.31612/2616-4868.4.2024.06.
Kim HJ, Song HY, Yang H. Emerging insights into microbiome therapeutics for urinary tract infections: a narrative review. Urogenit Tract Infect. 2025;20(1):4–16. doi: 10.14777/uti.2448034017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Annals of Mechnikov's Institute

This work is licensed under a Creative Commons Attribution 4.0 International License.